DE602005024186D1 - Inulin sulfate zur Behandlung von Osteoarthritis - Google Patents

Inulin sulfate zur Behandlung von Osteoarthritis

Info

Publication number
DE602005024186D1
DE602005024186D1 DE602005024186T DE602005024186T DE602005024186D1 DE 602005024186 D1 DE602005024186 D1 DE 602005024186D1 DE 602005024186 T DE602005024186 T DE 602005024186T DE 602005024186 T DE602005024186 T DE 602005024186T DE 602005024186 D1 DE602005024186 D1 DE 602005024186D1
Authority
DE
Germany
Prior art keywords
sulphate
inulin
treatment
sulphated
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024186T
Other languages
English (en)
Inventor
Pahi Francisco Javier Vila
Ferrer Josep Escaich
August Lodewijk Verbruggen
Milano Josep Verges
Roura Ramon Ruhi
Verson Carlos Raul Alaez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioiberica SA
Original Assignee
Bioiberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioiberica SA filed Critical Bioiberica SA
Publication of DE602005024186D1 publication Critical patent/DE602005024186D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
DE602005024186T 2004-02-27 2005-02-11 Inulin sulfate zur Behandlung von Osteoarthritis Active DE602005024186D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400464A ES2251289B1 (es) 2004-02-27 2004-02-27 Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
PCT/EP2005/001390 WO2005084610A2 (en) 2004-02-27 2005-02-11 New therapeutic use for a group of sulphated polysaccharides

Publications (1)

Publication Number Publication Date
DE602005024186D1 true DE602005024186D1 (de) 2010-11-25

Family

ID=34917281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024186T Active DE602005024186D1 (de) 2004-02-27 2005-02-11 Inulin sulfate zur Behandlung von Osteoarthritis

Country Status (15)

Country Link
US (1) US7816329B2 (de)
EP (1) EP1917018B1 (de)
JP (1) JP2007523925A (de)
AT (1) ATE484285T1 (de)
AU (1) AU2005218729A1 (de)
CA (1) CA2555616A1 (de)
CY (1) CY1110910T1 (de)
DE (1) DE602005024186D1 (de)
DK (1) DK1917018T3 (de)
ES (2) ES2251289B1 (de)
NZ (1) NZ549989A (de)
PL (1) PL1917018T3 (de)
PT (1) PT1917018E (de)
SI (1) SI1917018T1 (de)
WO (1) WO2005084610A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5002937B2 (ja) * 2005-10-03 2012-08-15 Ｊｎｃ株式会社 硫酸化多糖及びその製造法
ES2327480B1 (es) * 2007-06-15 2010-08-10 Bioiberica, S.A. "disacaridos para el tratamiento de tendones, ligamentos y huesos".
EP3393483A1 (de) * 2015-12-22 2018-10-31 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Auf gellangummi basierende hydrogele, verfahren und verwendung davon
RU2686075C1 (ru) * 2018-04-11 2019-04-24 Дмитрий Вениаминович Воробьев Биологически активное средство для лечения заболеваний опорно-двигательной системы и способ лечения заболеваний опорно-двигательной системы
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity
CN113730646A (zh) * 2021-08-27 2021-12-03 中国海洋大学 一种高载药可降解褐藻酸硫酸酯血管栓塞微球及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2686779A (en) 1949-07-18 1954-08-17 Phillips Petroleum Co Process for producing alkali metal sulfates of cellulose, inulin, dextrin, and starch
US4021545A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
US5145841A (en) * 1987-03-19 1992-09-08 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5063210A (en) 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
WO1992013541A1 (de) * 1991-01-30 1992-08-20 Hoechst Aktiengesellschaft Die verwendung substituierter polysaccharide zur behandlung von degenerativen gelenkerkrankungen
JP2844396B2 (ja) 1991-02-07 1999-01-06 ポーラ化成工業株式会社 化粧料
CA2060223C (en) 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5407581A (en) * 1992-03-17 1995-04-18 Asahi Medical Co., Ltd. Filter medium having a limited surface negative charge for treating a blood material
JP2003509074A (ja) * 1999-09-22 2003-03-11 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム ペット動物の活力を増加する方法
FR2816213B1 (fr) * 2000-11-03 2005-04-22 Goemar Lab Sa Medicament anti-inflammatoire et cicatrisant
WO2003006645A2 (en) * 2001-07-13 2003-01-23 Imclone Systems Incorporated Method and composition for inhibiting heparanase activity
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
DE602004010307T2 (de) 2003-12-02 2008-09-25 Universiteit Gent Verwendung von polysulfatiertem alginat in zellmatrix

Also Published As

Publication number Publication date
EP1917018B1 (de) 2010-10-13
JP2007523925A (ja) 2007-08-23
AU2005218729A1 (en) 2005-09-15
SI1917018T1 (sl) 2010-12-31
DK1917018T3 (da) 2011-01-31
ATE484285T1 (de) 2010-10-15
WO2005084610A3 (en) 2005-12-08
US20080051350A1 (en) 2008-02-28
ES2251289A1 (es) 2006-04-16
EP1917018A2 (de) 2008-05-07
PL1917018T3 (pl) 2011-03-31
ES2251289B1 (es) 2007-07-01
CA2555616A1 (en) 2005-09-15
US7816329B2 (en) 2010-10-19
NZ549989A (en) 2008-10-31
WO2005084610A2 (en) 2005-09-15
ES2354076T3 (es) 2011-03-09
PT1917018E (pt) 2010-12-10
CY1110910T1 (el) 2015-06-10

Similar Documents

Publication Publication Date Title
CY1110910T1 (el) Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων
Pereira Biological and therapeutic properties of the seaweed polysaccharides
IN2012DN03632A (de)
JP2015522539A5 (de)
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
MA33044B1 (fr) Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MY148405A (en) Immunogenic composition
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
RU2014131078A (ru) Способ выделения белковой композиции и жировой композиции из мяса птицы механической обвалки
AR082313A1 (es) Composicion farmaceutica de combinacion para tratar enfermedades o condiciones asociadas una enfermedad o condicion respiratoria
EA200901113A1 (ru) Применение хитозанов для лечения воспалительных заболеваний ногтей
HRP20231090T1 (hr) Pripravci i metode sinergističkog tretmana glikokaliksa
NO20070146L (no) 4-fenylpyrimidin-2-karbonitril-derivater
KR20110017819A (ko) 소화성 궤양과 십이지장 궤양 치료 및 예방을 위한 히알루론산 혼합물
MA30620B1 (fr) Carboxamides substitues
EA201391014A1 (ru) Способ производства композиции, содержащей местный анестетик, гепариноид и буфер
PL379512A1 (pl) Nowe metody i ich zastosowanie
RU2016116786A (ru) Иммуностимулятор
EA200970122A1 (ru) Фармацевтически приемлемые солевые и полиморфные формы малеата флюпиртина
UA97359C2 (en) Immunogenic composition
JP2014504628A5 (de)
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение
CN105998054A (zh) 脚气粉